Masiba, Esperanza S.
HRN: 26-89-38 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
CEFTRIAXONE 1G (VIAL)
03/27/2025
04/03/2025
IV
2g
OD
UTI
Waiting Final Action